"Innovation needs to happen, so we can minimize the number of patients who lose the battle to cancer.” Mohamed Zaki, M.D., Ph.D., vice president, global head of hematology development, AbbVie
Oncology Areas of Research
Our scientists put their focus into three groups: regulated cell death, immune-oncology, and tumor specific antigens.
Researchers are examining regulated cell death, trying to exploit the pathways a cell uses to induce its own demise in an orderly, programmed manner.
Immune-oncology is an area of research where scientists explore ways the body unleashes its own immune system to eradicate cancer cells.
Through our work in tumor-specific antigens, teams are researching targeted deliveries to cancer cells that could induce less collateral damage to the patient.